Clinicopathological and treatment data of the whole patient group (n = 138)
| Variable | Number of patients (%) |
|---|---|
| Sex | |
| Male | 105 (76) |
| Female | 33 (24) |
| Site | |
| Oropharynx | 88 (64) |
| Hypopharynx | 50 (36) |
| Tumour status | |
| T1 | 23 (17) |
| T2 | 46 (33) |
| T3 | 25 (18) |
| T4 | 44 (32) |
| Nodal status | |
| N0 | 81 (59) |
| N1 | 21 (15) |
| N2 | 32 (23) |
| N3 | 4 (3) |
| Distant metastases | |
| M0 | 132 (96) |
| M1 | 6 (4) |
| Stage | |
| I | 16 (12) |
| II | 28 (20) |
| III | 26 (19) |
| IV | 68 (49) |
| Histological differentiation | |
| Good | 34 (24) |
| Moderate | 63 (46) |
| Poor | 41 (30) |
| Performance status (Karnofsky) | |
| 90 | 8 (6) |
| 80 | 21 (15) |
| 70 | 62 (45) |
| 60 | 29 (21) |
| 50 | 15 (11) |
| 40 | 3 (2) |
| Primary treatment | |
| Radiotherapy | 86 (62) |
| Surgery | 8 (6) |
| Surgery and radiotherapy | 38 (28) |
| Chemotherapy | 2 (1) |
| No treatment | 4 (3) |
| Goal of the primary treatment | |
| Curative | 120 (87) |
| Palliative | 14 (10) |